SCHEMBL8986159

SCHEMBL8986159

O=CC1CCCNC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1161621 0.93 CCR2 (0.40)
Benzene SCHEMBL27483839 0.88 ALDH1A1 (0.40)
SCHEMBL5155720 0.80
SCHEMBL27392110 0.78 RAB9A (0.33)
SCHEMBL34015 0.74 CCR2 (0.43)
SCHEMBL9901036 0.74 CCR2 (0.43)
Nitrobenzene SCHEMBL27557416 0.74 ALDH1A1 (0.43)
SCHEMBL9120801 0.72 L3MBTL1 (0.34)
SCHEMBL17101670 0.72 CCR2 (0.42)
SCHEMBL31074860 0.72 CCR2 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010034110-A1 BETA-CARBOLINE SULPHONYLUREA DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS MERCK FROSST CANADA LTD. (CA) 2010-04-01 WO disclosed
US-20090306082-A1 NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLENMARK PHARMACEUTICALS S.A. (CH) 2009-12-10 US disclosed
EP-0476107-B1 PROCESS FOR IDENTIFYING CANDIDA ALBICANS BY MEANS OF CHROMOGENIC SUBSTANCES STAGO DIAGNOSTICA (FR) 1996-06-19 EP disclosed
US-5449612-A Process for identifying candida by means of chromogenic substances SERBIO (FR) 1995-09-12 US disclosed
WO-1991014787-A1 PROCESS FOR IDENTIFYING CANDIDA BY MEANS OF CHROMOGENIC SUBSTANCES SERBIO (FR) 1991-10-03 WO disclosed